In 2012, the US Preventive Services Working Group (USPSTF) reported that prostate-specific antigen screening reduced the risk of PC death, and the USPSTF recommended including prostate-specific antigen in PC screening (26). The gene discussed is KLK3; the disease is pachyonychia congenita.